nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—CHRM2—alcohol dependence	0.555	1	CbGaD
Solifenacin—CHRM1—Citalopram—alcohol dependence	0.158	0.661	CbGbCtD
Solifenacin—CYP3A4—Disulfiram—alcohol dependence	0.0475	0.198	CbGbCtD
Solifenacin—CYP3A4—Citalopram—alcohol dependence	0.0338	0.141	CbGbCtD
Solifenacin—Dysphonia—Naltrexone—alcohol dependence	0.00171	0.0184	CcSEcCtD
Solifenacin—Mequitazine—CHRM2—alcohol dependence	0.0017	1	CrCbGaD
Solifenacin—Delirium—Naltrexone—alcohol dependence	0.00164	0.0176	CcSEcCtD
Solifenacin—Gastrooesophageal reflux disease—Naltrexone—alcohol dependence	0.00156	0.0167	CcSEcCtD
Solifenacin—Torsade de pointes—Citalopram—alcohol dependence	0.00127	0.0137	CcSEcCtD
Solifenacin—Glaucoma—Citalopram—alcohol dependence	0.00118	0.0127	CcSEcCtD
Solifenacin—Dermatitis exfoliative—Acamprosate—alcohol dependence	0.00114	0.0123	CcSEcCtD
Solifenacin—Dysphonia—Citalopram—alcohol dependence	0.00108	0.0116	CcSEcCtD
Solifenacin—Atrial fibrillation—Naltrexone—alcohol dependence	0.00108	0.0116	CcSEcCtD
Solifenacin—Delirium—Citalopram—alcohol dependence	0.00104	0.0111	CcSEcCtD
Solifenacin—Liver function test abnormal—Acamprosate—alcohol dependence	0.000997	0.0107	CcSEcCtD
Solifenacin—Dry skin—Acamprosate—alcohol dependence	0.000989	0.0106	CcSEcCtD
Solifenacin—Gastrooesophageal reflux disease—Citalopram—alcohol dependence	0.000987	0.0106	CcSEcCtD
Solifenacin—Drug interaction—Citalopram—alcohol dependence	0.000961	0.0103	CcSEcCtD
Solifenacin—Somnolence—Disulfiram—alcohol dependence	0.000958	0.0103	CcSEcCtD
Solifenacin—Influenza—Acamprosate—alcohol dependence	0.000933	0.01	CcSEcCtD
Solifenacin—Abdominal pain upper—Naltrexone—alcohol dependence	0.000933	0.01	CcSEcCtD
Solifenacin—Fatigue—Disulfiram—alcohol dependence	0.000929	0.00998	CcSEcCtD
Solifenacin—Influenza—Naltrexone—alcohol dependence	0.000883	0.00949	CcSEcCtD
Solifenacin—Cystitis noninfective—Citalopram—alcohol dependence	0.000871	0.00936	CcSEcCtD
Solifenacin—Cystitis—Citalopram—alcohol dependence	0.000861	0.00925	CcSEcCtD
Solifenacin—Depression—Acamprosate—alcohol dependence	0.000829	0.00892	CcSEcCtD
Solifenacin—Dry eye—Citalopram—alcohol dependence	0.000823	0.00885	CcSEcCtD
Solifenacin—Urinary tract infection—Acamprosate—alcohol dependence	0.000809	0.00869	CcSEcCtD
Solifenacin—Bladder pain—Citalopram—alcohol dependence	0.000806	0.00867	CcSEcCtD
Solifenacin—Infestation NOS—Naltrexone—alcohol dependence	0.000787	0.00846	CcSEcCtD
Solifenacin—Infestation—Naltrexone—alcohol dependence	0.000787	0.00846	CcSEcCtD
Solifenacin—Depression—Naltrexone—alcohol dependence	0.000785	0.00844	CcSEcCtD
Solifenacin—Asthenia—Disulfiram—alcohol dependence	0.000773	0.00831	CcSEcCtD
Solifenacin—Urinary tract infection—Naltrexone—alcohol dependence	0.000765	0.00823	CcSEcCtD
Solifenacin—Hepatobiliary disease—Naltrexone—alcohol dependence	0.000744	0.008	CcSEcCtD
Solifenacin—Hallucination—Acamprosate—alcohol dependence	0.000743	0.00799	CcSEcCtD
Solifenacin—Pharyngitis—Acamprosate—alcohol dependence	0.000741	0.00797	CcSEcCtD
Solifenacin—Oedema peripheral—Acamprosate—alcohol dependence	0.000736	0.00791	CcSEcCtD
Solifenacin—Dizziness—Disulfiram—alcohol dependence	0.000712	0.00766	CcSEcCtD
Solifenacin—Hallucination—Naltrexone—alcohol dependence	0.000703	0.00756	CcSEcCtD
Solifenacin—Pharyngitis—Naltrexone—alcohol dependence	0.000701	0.00754	CcSEcCtD
Solifenacin—Connective tissue disorder—Naltrexone—alcohol dependence	0.000694	0.00746	CcSEcCtD
Solifenacin—Atrial fibrillation—Citalopram—alcohol dependence	0.000683	0.00734	CcSEcCtD
Solifenacin—Rash—Disulfiram—alcohol dependence	0.000679	0.0073	CcSEcCtD
Solifenacin—Headache—Disulfiram—alcohol dependence	0.000675	0.00725	CcSEcCtD
Solifenacin—Immune system disorder—Acamprosate—alcohol dependence	0.000675	0.00725	CcSEcCtD
Solifenacin—Eye disorder—Naltrexone—alcohol dependence	0.00066	0.0071	CcSEcCtD
Solifenacin—Cardiac disorder—Naltrexone—alcohol dependence	0.000656	0.00705	CcSEcCtD
Solifenacin—Mental disorder—Acamprosate—alcohol dependence	0.000654	0.00703	CcSEcCtD
Solifenacin—Malnutrition—Acamprosate—alcohol dependence	0.00065	0.00699	CcSEcCtD
Solifenacin—Angiopathy—Naltrexone—alcohol dependence	0.000641	0.00689	CcSEcCtD
Solifenacin—Immune system disorder—Naltrexone—alcohol dependence	0.000638	0.00686	CcSEcCtD
Solifenacin—Mediastinal disorder—Naltrexone—alcohol dependence	0.000637	0.00685	CcSEcCtD
Solifenacin—Dysgeusia—Acamprosate—alcohol dependence	0.000637	0.00684	CcSEcCtD
Solifenacin—Mental disorder—Naltrexone—alcohol dependence	0.000619	0.00666	CcSEcCtD
Solifenacin—Urinary retention—Citalopram—alcohol dependence	0.000615	0.00662	CcSEcCtD
Solifenacin—Malnutrition—Naltrexone—alcohol dependence	0.000615	0.00661	CcSEcCtD
Solifenacin—Dysgeusia—Naltrexone—alcohol dependence	0.000602	0.00648	CcSEcCtD
Solifenacin—Liver function test abnormal—Citalopram—alcohol dependence	0.000597	0.00642	CcSEcCtD
Solifenacin—Angioedema—Acamprosate—alcohol dependence	0.000594	0.00639	CcSEcCtD
Solifenacin—Dry skin—Citalopram—alcohol dependence	0.000593	0.00638	CcSEcCtD
Solifenacin—Abdominal pain upper—Citalopram—alcohol dependence	0.000591	0.00635	CcSEcCtD
Solifenacin—Vision blurred—Naltrexone—alcohol dependence	0.00058	0.00623	CcSEcCtD
Solifenacin—Palpitations—Acamprosate—alcohol dependence	0.000574	0.00618	CcSEcCtD
Solifenacin—Muscular weakness—Citalopram—alcohol dependence	0.000571	0.00614	CcSEcCtD
Solifenacin—Cough—Acamprosate—alcohol dependence	0.000567	0.0061	CcSEcCtD
Solifenacin—Angioedema—Naltrexone—alcohol dependence	0.000562	0.00604	CcSEcCtD
Solifenacin—Hypertension—Acamprosate—alcohol dependence	0.000561	0.00603	CcSEcCtD
Solifenacin—Influenza—Citalopram—alcohol dependence	0.000559	0.00601	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00055	0.00591	CcSEcCtD
Solifenacin—Palpitations—Naltrexone—alcohol dependence	0.000544	0.00584	CcSEcCtD
Solifenacin—Dry mouth—Acamprosate—alcohol dependence	0.000541	0.00582	CcSEcCtD
Solifenacin—Cough—Naltrexone—alcohol dependence	0.000537	0.00577	CcSEcCtD
Solifenacin—Confusional state—Acamprosate—alcohol dependence	0.000535	0.00575	CcSEcCtD
Solifenacin—Hypertension—Naltrexone—alcohol dependence	0.000531	0.00571	CcSEcCtD
Solifenacin—Anaphylactic shock—Acamprosate—alcohol dependence	0.000531	0.0057	CcSEcCtD
Solifenacin—Infection—Acamprosate—alcohol dependence	0.000527	0.00567	CcSEcCtD
Solifenacin—CHRM4—testis—alcohol dependence	0.000526	0.0557	CbGeAlD
Solifenacin—Dysuria—Citalopram—alcohol dependence	0.000523	0.00562	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00052	0.00559	CcSEcCtD
Solifenacin—Tachycardia—Acamprosate—alcohol dependence	0.000518	0.00557	CcSEcCtD
Solifenacin—CHRM4—nervous system—alcohol dependence	0.000516	0.0547	CbGeAlD
Solifenacin—Skin disorder—Acamprosate—alcohol dependence	0.000515	0.00554	CcSEcCtD
Solifenacin—Dry mouth—Naltrexone—alcohol dependence	0.000512	0.00551	CcSEcCtD
Solifenacin—CHRM2—forebrain—alcohol dependence	0.00051	0.054	CbGeAlD
Solifenacin—Confusional state—Naltrexone—alcohol dependence	0.000506	0.00544	CcSEcCtD
Solifenacin—Anaphylactic shock—Naltrexone—alcohol dependence	0.000502	0.0054	CcSEcCtD
Solifenacin—Infection—Naltrexone—alcohol dependence	0.000499	0.00536	CcSEcCtD
Solifenacin—Infestation NOS—Citalopram—alcohol dependence	0.000499	0.00536	CcSEcCtD
Solifenacin—Infestation—Citalopram—alcohol dependence	0.000499	0.00536	CcSEcCtD
Solifenacin—Depression—Citalopram—alcohol dependence	0.000497	0.00535	CcSEcCtD
Solifenacin—CHRM4—central nervous system—alcohol dependence	0.000497	0.0526	CbGeAlD
Solifenacin—Nervous system disorder—Naltrexone—alcohol dependence	0.000492	0.00529	CcSEcCtD
Solifenacin—Tachycardia—Naltrexone—alcohol dependence	0.00049	0.00527	CcSEcCtD
Solifenacin—Skin disorder—Naltrexone—alcohol dependence	0.000488	0.00524	CcSEcCtD
Solifenacin—Urinary tract infection—Citalopram—alcohol dependence	0.000485	0.00521	CcSEcCtD
Solifenacin—Somnolence—Acamprosate—alcohol dependence	0.000472	0.00507	CcSEcCtD
Solifenacin—Hepatobiliary disease—Citalopram—alcohol dependence	0.000472	0.00507	CcSEcCtD
Solifenacin—Dyspepsia—Acamprosate—alcohol dependence	0.000467	0.00502	CcSEcCtD
Solifenacin—CHRM1—forebrain—alcohol dependence	0.000464	0.0492	CbGeAlD
Solifenacin—Decreased appetite—Acamprosate—alcohol dependence	0.000461	0.00496	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000458	0.00492	CcSEcCtD
Solifenacin—Constipation—Acamprosate—alcohol dependence	0.000454	0.00488	CcSEcCtD
Solifenacin—Somnolence—Naltrexone—alcohol dependence	0.000446	0.0048	CcSEcCtD
Solifenacin—Hallucination—Citalopram—alcohol dependence	0.000445	0.00479	CcSEcCtD
Solifenacin—Pharyngitis—Citalopram—alcohol dependence	0.000444	0.00478	CcSEcCtD
Solifenacin—Urinary tract disorder—Citalopram—alcohol dependence	0.000442	0.00475	CcSEcCtD
Solifenacin—Oedema peripheral—Citalopram—alcohol dependence	0.000441	0.00474	CcSEcCtD
Solifenacin—Connective tissue disorder—Citalopram—alcohol dependence	0.00044	0.00473	CcSEcCtD
Solifenacin—Urethral disorder—Citalopram—alcohol dependence	0.000439	0.00472	CcSEcCtD
Solifenacin—Feeling abnormal—Acamprosate—alcohol dependence	0.000437	0.0047	CcSEcCtD
Solifenacin—Decreased appetite—Naltrexone—alcohol dependence	0.000436	0.00469	CcSEcCtD
Solifenacin—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000434	0.00466	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000433	0.00466	CcSEcCtD
Solifenacin—Fatigue—Naltrexone—alcohol dependence	0.000433	0.00465	CcSEcCtD
Solifenacin—CHRM2—cardiovascular system—alcohol dependence	0.000431	0.0457	CbGeAlD
Solifenacin—Constipation—Naltrexone—alcohol dependence	0.000429	0.00462	CcSEcCtD
Solifenacin—Erythema multiforme—Citalopram—alcohol dependence	0.000423	0.00455	CcSEcCtD
Solifenacin—Urticaria—Acamprosate—alcohol dependence	0.000421	0.00453	CcSEcCtD
Solifenacin—Abdominal pain—Acamprosate—alcohol dependence	0.000419	0.00451	CcSEcCtD
Solifenacin—Eye disorder—Citalopram—alcohol dependence	0.000418	0.0045	CcSEcCtD
Solifenacin—Cardiac disorder—Citalopram—alcohol dependence	0.000415	0.00447	CcSEcCtD
Solifenacin—CHRM3—forebrain—alcohol dependence	0.000415	0.044	CbGeAlD
Solifenacin—Feeling abnormal—Naltrexone—alcohol dependence	0.000414	0.00445	CcSEcCtD
Solifenacin—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00041	0.00441	CcSEcCtD
Solifenacin—Angiopathy—Citalopram—alcohol dependence	0.000406	0.00437	CcSEcCtD
Solifenacin—Immune system disorder—Citalopram—alcohol dependence	0.000404	0.00435	CcSEcCtD
Solifenacin—Mediastinal disorder—Citalopram—alcohol dependence	0.000403	0.00434	CcSEcCtD
Solifenacin—CHRM5—nervous system—alcohol dependence	0.000403	0.0427	CbGeAlD
Solifenacin—Urticaria—Naltrexone—alcohol dependence	0.000399	0.00429	CcSEcCtD
Solifenacin—Abdominal pain—Naltrexone—alcohol dependence	0.000397	0.00427	CcSEcCtD
Solifenacin—CHRM4—brain—alcohol dependence	0.000394	0.0418	CbGeAlD
Solifenacin—CHRM1—cardiovascular system—alcohol dependence	0.000393	0.0416	CbGeAlD
Solifenacin—Mental disorder—Citalopram—alcohol dependence	0.000392	0.00422	CcSEcCtD
Solifenacin—Hypersensitivity—Acamprosate—alcohol dependence	0.000391	0.0042	CcSEcCtD
Solifenacin—Malnutrition—Citalopram—alcohol dependence	0.00039	0.00419	CcSEcCtD
Solifenacin—CHRM5—central nervous system—alcohol dependence	0.000388	0.0411	CbGeAlD
Solifenacin—Dysgeusia—Citalopram—alcohol dependence	0.000382	0.0041	CcSEcCtD
Solifenacin—Asthenia—Acamprosate—alcohol dependence	0.000381	0.00409	CcSEcCtD
Solifenacin—Pruritus—Acamprosate—alcohol dependence	0.000375	0.00404	CcSEcCtD
Solifenacin—Hypersensitivity—Naltrexone—alcohol dependence	0.00037	0.00398	CcSEcCtD
Solifenacin—Vision blurred—Citalopram—alcohol dependence	0.000367	0.00395	CcSEcCtD
Solifenacin—Asthenia—Naltrexone—alcohol dependence	0.00036	0.00387	CcSEcCtD
Solifenacin—Angioedema—Citalopram—alcohol dependence	0.000356	0.00383	CcSEcCtD
Solifenacin—Pruritus—Naltrexone—alcohol dependence	0.000355	0.00382	CcSEcCtD
Solifenacin—Dizziness—Acamprosate—alcohol dependence	0.000351	0.00377	CcSEcCtD
Solifenacin—Palpitations—Citalopram—alcohol dependence	0.000344	0.0037	CcSEcCtD
Solifenacin—Cough—Citalopram—alcohol dependence	0.00034	0.00366	CcSEcCtD
Solifenacin—Vomiting—Acamprosate—alcohol dependence	0.000337	0.00363	CcSEcCtD
Solifenacin—Hypertension—Citalopram—alcohol dependence	0.000336	0.00362	CcSEcCtD
Solifenacin—Rash—Acamprosate—alcohol dependence	0.000335	0.0036	CcSEcCtD
Solifenacin—Dermatitis—Acamprosate—alcohol dependence	0.000334	0.00359	CcSEcCtD
Solifenacin—Headache—Acamprosate—alcohol dependence	0.000332	0.00357	CcSEcCtD
Solifenacin—Dizziness—Naltrexone—alcohol dependence	0.000332	0.00357	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000329	0.00354	CcSEcCtD
Solifenacin—Dry mouth—Citalopram—alcohol dependence	0.000324	0.00349	CcSEcCtD
Solifenacin—Confusional state—Citalopram—alcohol dependence	0.000321	0.00345	CcSEcCtD
Solifenacin—Vomiting—Naltrexone—alcohol dependence	0.000319	0.00343	CcSEcCtD
Solifenacin—Anaphylactic shock—Citalopram—alcohol dependence	0.000318	0.00342	CcSEcCtD
Solifenacin—Rash—Naltrexone—alcohol dependence	0.000317	0.0034	CcSEcCtD
Solifenacin—Dermatitis—Naltrexone—alcohol dependence	0.000316	0.0034	CcSEcCtD
Solifenacin—Infection—Citalopram—alcohol dependence	0.000316	0.0034	CcSEcCtD
Solifenacin—Nausea—Acamprosate—alcohol dependence	0.000315	0.00339	CcSEcCtD
Solifenacin—Headache—Naltrexone—alcohol dependence	0.000314	0.00338	CcSEcCtD
Solifenacin—Nervous system disorder—Citalopram—alcohol dependence	0.000312	0.00335	CcSEcCtD
Solifenacin—Tachycardia—Citalopram—alcohol dependence	0.00031	0.00334	CcSEcCtD
Solifenacin—Skin disorder—Citalopram—alcohol dependence	0.000309	0.00332	CcSEcCtD
Solifenacin—CHRM5—brain—alcohol dependence	0.000308	0.0327	CbGeAlD
Solifenacin—Nausea—Naltrexone—alcohol dependence	0.000298	0.00321	CcSEcCtD
Solifenacin—CHRM2—endocrine gland—alcohol dependence	0.000296	0.0313	CbGeAlD
Solifenacin—CHRM3—digestive system—alcohol dependence	0.000292	0.0309	CbGeAlD
Solifenacin—Somnolence—Citalopram—alcohol dependence	0.000283	0.00304	CcSEcCtD
Solifenacin—Dyspepsia—Citalopram—alcohol dependence	0.00028	0.00301	CcSEcCtD
Solifenacin—CHRM2—nervous system—alcohol dependence	0.000277	0.0293	CbGeAlD
Solifenacin—Decreased appetite—Citalopram—alcohol dependence	0.000276	0.00297	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000275	0.00295	CcSEcCtD
Solifenacin—Fatigue—Citalopram—alcohol dependence	0.000274	0.00295	CcSEcCtD
Solifenacin—Constipation—Citalopram—alcohol dependence	0.000272	0.00292	CcSEcCtD
Solifenacin—CHRM1—endocrine gland—alcohol dependence	0.000269	0.0285	CbGeAlD
Solifenacin—CHRM2—central nervous system—alcohol dependence	0.000267	0.0282	CbGeAlD
Solifenacin—Feeling abnormal—Citalopram—alcohol dependence	0.000262	0.00282	CcSEcCtD
Solifenacin—Gastrointestinal pain—Citalopram—alcohol dependence	0.00026	0.0028	CcSEcCtD
Solifenacin—Urticaria—Citalopram—alcohol dependence	0.000253	0.00272	CcSEcCtD
Solifenacin—CHRM1—nervous system—alcohol dependence	0.000252	0.0267	CbGeAlD
Solifenacin—Abdominal pain—Citalopram—alcohol dependence	0.000251	0.0027	CcSEcCtD
Solifenacin—CHRM1—central nervous system—alcohol dependence	0.000243	0.0257	CbGeAlD
Solifenacin—CHRM3—endocrine gland—alcohol dependence	0.000241	0.0255	CbGeAlD
Solifenacin—Hypersensitivity—Citalopram—alcohol dependence	0.000234	0.00252	CcSEcCtD
Solifenacin—CHRM3—testis—alcohol dependence	0.00023	0.0243	CbGeAlD
Solifenacin—Asthenia—Citalopram—alcohol dependence	0.000228	0.00245	CcSEcCtD
Solifenacin—CHRM3—nervous system—alcohol dependence	0.000226	0.0239	CbGeAlD
Solifenacin—Pruritus—Citalopram—alcohol dependence	0.000225	0.00242	CcSEcCtD
Solifenacin—CHRM3—central nervous system—alcohol dependence	0.000217	0.023	CbGeAlD
Solifenacin—CHRM2—brain—alcohol dependence	0.000212	0.0224	CbGeAlD
Solifenacin—Dizziness—Citalopram—alcohol dependence	0.00021	0.00226	CcSEcCtD
Solifenacin—Vomiting—Citalopram—alcohol dependence	0.000202	0.00217	CcSEcCtD
Solifenacin—Rash—Citalopram—alcohol dependence	0.000201	0.00216	CcSEcCtD
Solifenacin—Dermatitis—Citalopram—alcohol dependence	0.0002	0.00215	CcSEcCtD
Solifenacin—Headache—Citalopram—alcohol dependence	0.000199	0.00214	CcSEcCtD
Solifenacin—CHRM1—brain—alcohol dependence	0.000193	0.0204	CbGeAlD
Solifenacin—Nausea—Citalopram—alcohol dependence	0.000189	0.00203	CcSEcCtD
Solifenacin—CHRM3—brain—alcohol dependence	0.000172	0.0183	CbGeAlD
Solifenacin—CYP3A4—digestive system—alcohol dependence	0.00016	0.017	CbGeAlD
Solifenacin—CYP3A4—blood—alcohol dependence	0.000153	0.0162	CbGeAlD
Solifenacin—CYP3A4—endocrine gland—alcohol dependence	0.000132	0.014	CbGeAlD
Solifenacin—CYP3A4—nervous system—alcohol dependence	0.000124	0.0131	CbGeAlD
Solifenacin—CYP3A4—liver—alcohol dependence	0.000119	0.0126	CbGeAlD
Solifenacin—CYP3A4—central nervous system—alcohol dependence	0.000119	0.0126	CbGeAlD
Solifenacin—CHRM3—GPCR downstream signaling—CRHR1—alcohol dependence	5.14e-05	0.000505	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—DRD4—alcohol dependence	5.12e-05	0.000504	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ADH4—alcohol dependence	5.11e-05	0.000503	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CRH—alcohol dependence	5.09e-05	0.000501	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—HTR1B—alcohol dependence	5.09e-05	0.000501	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CRHR1—alcohol dependence	5.09e-05	0.0005	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—PDYN—alcohol dependence	5.03e-05	0.000495	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—PDYN—alcohol dependence	5.02e-05	0.000494	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—PDYN—alcohol dependence	4.97e-05	0.000489	CbGpPWpGaD
Solifenacin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	4.95e-05	0.000487	CbGpPWpGaD
Solifenacin—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	4.91e-05	0.000483	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—DRD4—alcohol dependence	4.9e-05	0.000482	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—CNR1—alcohol dependence	4.89e-05	0.000481	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CHRM2—alcohol dependence	4.84e-05	0.000477	CbGpPWpGaD
Solifenacin—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	4.84e-05	0.000476	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CHRM2—alcohol dependence	4.83e-05	0.000475	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—AVP—alcohol dependence	4.79e-05	0.000471	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—EP300—alcohol dependence	4.78e-05	0.00047	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—AVP—alcohol dependence	4.77e-05	0.00047	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—HTR7—alcohol dependence	4.77e-05	0.000469	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—DRD2—alcohol dependence	4.77e-05	0.000469	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—AVP—alcohol dependence	4.73e-05	0.000465	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—POMC—alcohol dependence	4.72e-05	0.000464	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—CNR1—alcohol dependence	4.68e-05	0.000461	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CRHR1—alcohol dependence	4.68e-05	0.00046	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CRHR1—alcohol dependence	4.66e-05	0.000459	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—DRD4—alcohol dependence	4.65e-05	0.000457	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CRHR1—alcohol dependence	4.62e-05	0.000454	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—OPRK1—alcohol dependence	4.61e-05	0.000454	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—OPRD1—alcohol dependence	4.6e-05	0.000453	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—OPRK1—alcohol dependence	4.6e-05	0.000453	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—HTR7—alcohol dependence	4.57e-05	0.000449	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—DRD2—alcohol dependence	4.57e-05	0.000449	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—OPRK1—alcohol dependence	4.55e-05	0.000448	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—POMC—alcohol dependence	4.52e-05	0.000445	CbGpPWpGaD
Solifenacin—CYP3A4—Biological oxidations—GGT1—alcohol dependence	4.51e-05	0.000443	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—DRD4—alcohol dependence	4.45e-05	0.000438	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—OPRM1—alcohol dependence	4.45e-05	0.000438	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—CNR1—alcohol dependence	4.44e-05	0.000437	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—OPRM1—alcohol dependence	4.43e-05	0.000436	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PDYN—alcohol dependence	4.41e-05	0.000434	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—OPRD1—alcohol dependence	4.4e-05	0.000433	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CHRM2—alcohol dependence	4.4e-05	0.000433	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—OPRM1—alcohol dependence	4.39e-05	0.000432	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CHRM2—alcohol dependence	4.38e-05	0.000431	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ADH7—alcohol dependence	4.35e-05	0.000428	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—HTR7—alcohol dependence	4.33e-05	0.000426	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—DRD2—alcohol dependence	4.33e-05	0.000426	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CNR1—alcohol dependence	4.25e-05	0.000418	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PDYN—alcohol dependence	4.22e-05	0.000415	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	4.18e-05	0.000411	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GGT2—alcohol dependence	4.17e-05	0.00041	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	4.17e-05	0.00041	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—HTR7—alcohol dependence	4.15e-05	0.000408	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—DRD2—alcohol dependence	4.15e-05	0.000408	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	4.13e-05	0.000406	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CRHR1—alcohol dependence	4.1e-05	0.000403	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—WASF2—alcohol dependence	4.1e-05	0.000403	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—NPY—alcohol dependence	4.09e-05	0.000403	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—NPY—alcohol dependence	4.08e-05	0.000401	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—NPY—alcohol dependence	4.04e-05	0.000398	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—OPRM1—alcohol dependence	4.04e-05	0.000397	CbGpPWpGaD
Solifenacin—CYP3A4—Biological oxidations—MAOA—alcohol dependence	4.04e-05	0.000397	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—OPRM1—alcohol dependence	4.03e-05	0.000396	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—AVP—alcohol dependence	4.01e-05	0.000395	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—OPRM1—alcohol dependence	3.99e-05	0.000392	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—HTR2A—alcohol dependence	3.98e-05	0.000392	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—HTR2A—alcohol dependence	3.97e-05	0.000391	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—EP300—alcohol dependence	3.95e-05	0.000389	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CRH—alcohol dependence	3.95e-05	0.000389	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—HTR1B—alcohol dependence	3.95e-05	0.000389	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CRH—alcohol dependence	3.94e-05	0.000387	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—HTR1B—alcohol dependence	3.94e-05	0.000387	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—HTR2A—alcohol dependence	3.93e-05	0.000387	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—WASF1—alcohol dependence	3.93e-05	0.000387	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—WASF2—alcohol dependence	3.93e-05	0.000386	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CRHR1—alcohol dependence	3.93e-05	0.000386	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—HTR1B—alcohol dependence	3.9e-05	0.000384	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CRH—alcohol dependence	3.9e-05	0.000384	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CHRM2—alcohol dependence	3.85e-05	0.000379	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—AVP—alcohol dependence	3.84e-05	0.000378	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ADH1B—alcohol dependence	3.81e-05	0.000375	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—WASF1—alcohol dependence	3.76e-05	0.00037	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—NPY—alcohol dependence	3.72e-05	0.000366	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—NPY—alcohol dependence	3.7e-05	0.000365	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CHRM2—alcohol dependence	3.69e-05	0.000363	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—NPY—alcohol dependence	3.67e-05	0.000361	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—AVP—alcohol dependence	3.64e-05	0.000359	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HTR1B—alcohol dependence	3.59e-05	0.000353	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CRH—alcohol dependence	3.59e-05	0.000353	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HTR1B—alcohol dependence	3.57e-05	0.000352	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CRH—alcohol dependence	3.57e-05	0.000352	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CRH—alcohol dependence	3.54e-05	0.000348	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HTR1B—alcohol dependence	3.54e-05	0.000348	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—OPRM1—alcohol dependence	3.54e-05	0.000348	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—AVP—alcohol dependence	3.49e-05	0.000343	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—DRD4—alcohol dependence	3.45e-05	0.00034	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—DRD4—alcohol dependence	3.44e-05	0.000339	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—DRD4—alcohol dependence	3.41e-05	0.000335	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—OPRM1—alcohol dependence	3.39e-05	0.000333	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—HTR2A—alcohol dependence	3.34e-05	0.000329	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CNR1—alcohol dependence	3.3e-05	0.000324	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CNR1—alcohol dependence	3.29e-05	0.000323	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NPY—alcohol dependence	3.26e-05	0.00032	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CNR1—alcohol dependence	3.25e-05	0.00032	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—HTR7—alcohol dependence	3.22e-05	0.000316	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—DRD2—alcohol dependence	3.22e-05	0.000316	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—HTR7—alcohol dependence	3.2e-05	0.000315	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—DRD2—alcohol dependence	3.2e-05	0.000315	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—HTR2A—alcohol dependence	3.2e-05	0.000315	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—POMC—alcohol dependence	3.18e-05	0.000313	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—HTR7—alcohol dependence	3.17e-05	0.000312	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—DRD2—alcohol dependence	3.17e-05	0.000312	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—POMC—alcohol dependence	3.17e-05	0.000312	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—MAOB—alcohol dependence	3.16e-05	0.000311	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—POMC—alcohol dependence	3.14e-05	0.000309	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CRH—alcohol dependence	3.14e-05	0.000309	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HTR1B—alcohol dependence	3.14e-05	0.000309	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—DRD4—alcohol dependence	3.13e-05	0.000308	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—DRD4—alcohol dependence	3.12e-05	0.000307	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NPY—alcohol dependence	3.12e-05	0.000307	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—OPRD1—alcohol dependence	3.1e-05	0.000305	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—DRD4—alcohol dependence	3.09e-05	0.000304	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—OPRD1—alcohol dependence	3.09e-05	0.000304	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—OPRD1—alcohol dependence	3.06e-05	0.000301	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—HTR2A—alcohol dependence	3.03e-05	0.000298	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HTR1B—alcohol dependence	3.01e-05	0.000296	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CRH—alcohol dependence	3.01e-05	0.000296	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CNR1—alcohol dependence	2.99e-05	0.000294	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CNR1—alcohol dependence	2.98e-05	0.000294	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PDYN—alcohol dependence	2.97e-05	0.000293	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PDYN—alcohol dependence	2.96e-05	0.000292	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CNR1—alcohol dependence	2.95e-05	0.000291	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PDYN—alcohol dependence	2.93e-05	0.000289	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HTR7—alcohol dependence	2.92e-05	0.000287	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—DRD2—alcohol dependence	2.92e-05	0.000287	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—DRD2—alcohol dependence	2.91e-05	0.000286	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HTR7—alcohol dependence	2.91e-05	0.000286	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—HTR2A—alcohol dependence	2.9e-05	0.000286	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HTR7—alcohol dependence	2.88e-05	0.000284	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—DRD2—alcohol dependence	2.88e-05	0.000284	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ADH6—alcohol dependence	2.84e-05	0.000279	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CRHR1—alcohol dependence	2.76e-05	0.000272	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—WASF2—alcohol dependence	2.76e-05	0.000272	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—WASF2—alcohol dependence	2.75e-05	0.000271	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CRHR1—alcohol dependence	2.75e-05	0.000271	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—DRD4—alcohol dependence	2.75e-05	0.00027	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CRHR1—alcohol dependence	2.73e-05	0.000268	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—WASF2—alcohol dependence	2.73e-05	0.000268	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—AVP—alcohol dependence	2.71e-05	0.000266	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—AVP—alcohol dependence	2.7e-05	0.000265	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ALDH2—alcohol dependence	2.69e-05	0.000264	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—AVP—alcohol dependence	2.67e-05	0.000263	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—POMC—alcohol dependence	2.67e-05	0.000262	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—WASF1—alcohol dependence	2.65e-05	0.000261	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—WASF1—alcohol dependence	2.64e-05	0.00026	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—DRD4—alcohol dependence	2.63e-05	0.000259	CbGpPWpGaD
Solifenacin—CYP3A4—Biological oxidations—POMC—alcohol dependence	2.63e-05	0.000259	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CNR1—alcohol dependence	2.62e-05	0.000258	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—WASF1—alcohol dependence	2.62e-05	0.000257	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CHRM2—alcohol dependence	2.6e-05	0.000256	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CHRM2—alcohol dependence	2.59e-05	0.000255	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—DRD2—alcohol dependence	2.56e-05	0.000252	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HTR7—alcohol dependence	2.56e-05	0.000252	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—POMC—alcohol dependence	2.55e-05	0.000251	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CNR1—alcohol dependence	2.51e-05	0.000247	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—AVP—alcohol dependence	2.46e-05	0.000242	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—AVP—alcohol dependence	2.45e-05	0.000241	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HTR7—alcohol dependence	2.45e-05	0.000241	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—DRD2—alcohol dependence	2.45e-05	0.000241	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—AVP—alcohol dependence	2.43e-05	0.000239	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—POMC—alcohol dependence	2.42e-05	0.000238	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—OPRM1—alcohol dependence	2.39e-05	0.000235	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—OPRM1—alcohol dependence	2.38e-05	0.000234	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—OPRM1—alcohol dependence	2.35e-05	0.000232	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ADH1A—alcohol dependence	2.35e-05	0.000231	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—POMC—alcohol dependence	2.32e-05	0.000228	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GOT2—alcohol dependence	2.28e-05	0.000225	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—HTR2A—alcohol dependence	2.25e-05	0.000222	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—HTR2A—alcohol dependence	2.24e-05	0.000221	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—HTR2A—alcohol dependence	2.22e-05	0.000219	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NPY—alcohol dependence	2.2e-05	0.000216	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NPY—alcohol dependence	2.19e-05	0.000215	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NPY—alcohol dependence	2.17e-05	0.000213	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—AVP—alcohol dependence	2.15e-05	0.000212	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CYP2E1—alcohol dependence	2.15e-05	0.000211	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HTR1B—alcohol dependence	2.12e-05	0.000208	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CRH—alcohol dependence	2.12e-05	0.000208	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HTR1B—alcohol dependence	2.11e-05	0.000208	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CRH—alcohol dependence	2.11e-05	0.000208	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CRH—alcohol dependence	2.09e-05	0.000206	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HTR1B—alcohol dependence	2.09e-05	0.000206	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—AVP—alcohol dependence	2.06e-05	0.000203	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HTR2A—alcohol dependence	2.04e-05	0.000201	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HTR2A—alcohol dependence	2.04e-05	0.000201	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HTR2A—alcohol dependence	2.02e-05	0.000199	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ADH4—alcohol dependence	2e-05	0.000197	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GGT1—alcohol dependence	1.97e-05	0.000194	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GOT1—alcohol dependence	1.97e-05	0.000194	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—DRD4—alcohol dependence	1.85e-05	0.000182	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—DRD4—alcohol dependence	1.85e-05	0.000182	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—DRD4—alcohol dependence	1.83e-05	0.00018	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—POMC—alcohol dependence	1.8e-05	0.000177	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—POMC—alcohol dependence	1.79e-05	0.000176	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HTR2A—alcohol dependence	1.79e-05	0.000176	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—POMC—alcohol dependence	1.78e-05	0.000175	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CNR1—alcohol dependence	1.77e-05	0.000174	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—MAOA—alcohol dependence	1.77e-05	0.000174	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CNR1—alcohol dependence	1.76e-05	0.000173	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CNR1—alcohol dependence	1.75e-05	0.000172	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HTR7—alcohol dependence	1.72e-05	0.00017	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—DRD2—alcohol dependence	1.72e-05	0.00017	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HTR7—alcohol dependence	1.72e-05	0.000169	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—DRD2—alcohol dependence	1.72e-05	0.000169	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HTR2A—alcohol dependence	1.72e-05	0.000169	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—DRD2—alcohol dependence	1.7e-05	0.000168	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HTR7—alcohol dependence	1.7e-05	0.000168	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ADH7—alcohol dependence	1.7e-05	0.000167	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—POMC—alcohol dependence	1.63e-05	0.000161	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GGT2—alcohol dependence	1.63e-05	0.00016	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—POMC—alcohol dependence	1.63e-05	0.00016	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—POMC—alcohol dependence	1.61e-05	0.000159	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ADH1B—alcohol dependence	1.49e-05	0.000147	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—AVP—alcohol dependence	1.45e-05	0.000143	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—AVP—alcohol dependence	1.45e-05	0.000142	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—AVP—alcohol dependence	1.43e-05	0.000141	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—POMC—alcohol dependence	1.43e-05	0.000141	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—POMC—alcohol dependence	1.37e-05	0.000135	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—MAOB—alcohol dependence	1.23e-05	0.000122	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HTR2A—alcohol dependence	1.21e-05	0.000119	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HTR2A—alcohol dependence	1.2e-05	0.000118	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HTR2A—alcohol dependence	1.19e-05	0.000117	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—POMC—alcohol dependence	1.15e-05	0.000113	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.05e-05	0.000103	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—POMC—alcohol dependence	9.65e-06	9.49e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—POMC—alcohol dependence	9.62e-06	9.46e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—POMC—alcohol dependence	9.52e-06	9.37e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—EP300—alcohol dependence	9.49e-06	9.34e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—EP300—alcohol dependence	9.09e-06	8.94e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GOT2—alcohol dependence	8.93e-06	8.78e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP2E1—alcohol dependence	8.39e-06	8.26e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GOT1—alcohol dependence	7.71e-06	7.58e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GGT1—alcohol dependence	7.71e-06	7.58e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—EP300—alcohol dependence	7.63e-06	7.51e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—MAOA—alcohol dependence	6.91e-06	6.8e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—EP300—alcohol dependence	6.4e-06	6.3e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—EP300—alcohol dependence	6.38e-06	6.28e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—EP300—alcohol dependence	6.32e-06	6.22e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—POMC—alcohol dependence	4.5e-06	4.42e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—EP300—alcohol dependence	2.98e-06	2.93e-05	CbGpPWpGaD
